See more : Grifols, S.A. (GRF.MC) Income Statement Analysis – Financial Results
Complete financial analysis of Living Cell Technologies Limited (LVCLF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Living Cell Technologies Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Core Laboratories N.V. (CLB) Income Statement Analysis – Financial Results
- Medicskin Holdings Limited (8307.HK) Income Statement Analysis – Financial Results
- Bilfinger SE (GBF.DE) Income Statement Analysis – Financial Results
- Formuepleje Globale Aktier (FPIGA.CO) Income Statement Analysis – Financial Results
- Consolidated Edison, Inc. (0I35.L) Income Statement Analysis – Financial Results
Living Cell Technologies Limited (LVCLF)
About Living Cell Technologies Limited
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 125.20K | 42.02K | 3.41K | 268.18K | 3.17K | 9.77K | 121.40K | 115.28K | 120.09K | 611.96K | 7.39M | 7.58M | 3.71M | 176.54K | 517.09K | 186.46K | 51.95K | 18.29K | 1.31K | 65.41K | 72.71K |
Cost of Revenue | 0.00 | 557.00 | 743.00 | 49.31K | 0.00 | 0.00 | 0.00 | 0.00 | 109.99K | 581.58K | 6.78M | 7.07M | 3.42M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 125.20K | 41.46K | 2.66K | 218.87K | 3.17K | 9.77K | 121.40K | 115.28K | 10.10K | 30.38K | 618.64K | 513.00K | 285.00K | 176.54K | 517.09K | 186.46K | 51.95K | 18.29K | 1.31K | 65.41K | 72.71K |
Gross Profit Ratio | 100.00% | 98.67% | 78.18% | 81.61% | 100.00% | 100.00% | 100.00% | 100.00% | 8.41% | 4.96% | 8.37% | 6.77% | 7.69% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 738.98K | 1.31M | 1.46M | 1.61M | 2.38M | 3.33M | 3.50M | 4.44M | 2.36M | 1.77M | 487.36K | 396.00K | 2.62M | 5.06M | 1.46M | 1.27M | 651.03K | 1.15M | 1.07M | 1.37M | 0.00 |
General & Administrative | 201.42K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.77M | 1.85M | 1.63M | 1.54M | 1.71M | 1.26M | 1.81M | 3.69M | 3.72M | 3.72M | 3.48M | 3.95M | 4.04M | 3.12M | 917.36K |
Selling & Marketing | 764.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 99.00K | 0.00 | 218.63K | 246.22K | 182.21K | 80.01K | 56.31K | 120.85K | 0.00 |
SG&A | 965.95K | 819.34K | 912.18K | 620.30K | 694.37K | 738.59K | 1.77M | 1.85M | 1.63M | 1.54M | 1.71M | 1.26M | 1.81M | 3.69M | 3.94M | 3.96M | 3.66M | 4.03M | 4.09M | 3.24M | 917.36K |
Other Expenses | 497.90K | -20.18K | 12.93K | 365.79K | 1.74M | 509.26K | 3.48M | 816.22K | 837.73K | 112.10K | 556.46K | 2.99M | 11.95M | 1.64M | 1.21M | 1.29M | 129.32K | 1.14M | 187.22K | -550.43K | -1.19M |
Operating Expenses | 2.20M | 2.13M | 2.38M | 2.28M | 3.17M | 4.17M | 4.39M | 5.37M | 4.05M | 3.32M | 2.20M | 1.67M | 4.54M | 9.09M | 7.57M | 7.99M | 7.07M | 6.95M | 7.11M | 5.76M | 1.04M |
Cost & Expenses | 2.20M | 2.13M | 2.38M | 2.28M | 3.17M | 4.17M | 4.39M | 5.37M | 4.16M | 3.90M | 8.98M | 8.73M | 7.96M | 9.09M | 7.57M | 7.99M | 7.07M | 6.95M | 7.11M | 5.76M | 1.04M |
Interest Income | 125.20K | 42.02K | 3.41K | 7.60K | 55.61K | 123.25K | 149.48K | 142.16K | 123.17K | 203.69K | 216.35K | 154.00K | 129.00K | 141.99K | 166.29K | 390.90K | 292.03K | 97.21K | 103.52K | 160.06K | 28.76K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.48K | 13.13K | 11.00K | 13.00K | 83.00 | 0.00 | 0.00 | 202.13K | 294.00K | 1.86K | 7.64K | 23.02K |
Depreciation & Amortization | 532.00 | 557.00 | 743.00 | 49.31K | 70.95K | 52.30K | 62.07K | 75.12K | 49.50K | 3.81K | 7.13K | 6.00K | 113.00K | 343.38K | 367.64K | 256.96K | 194.55K | 197.56K | 188.34K | 146.56K | 53.87K |
EBITDA | -1.58M | -1.48M | -2.36M | -1.34M | -3.15M | -4.11M | -4.21M | -5.18M | -3.99M | -7.03M | -6.76M | -2.96M | 5.80M | -8.57M | -6.69M | -7.55M | -6.40M | -5.50M | -6.63M | -5.94M | -2.08M |
EBITDA Ratio | -1,261.34% | -5,066.95% | -69,419.85% | -849.73% | -99,303.98% | -42,072.12% | -3,466.65% | -4,491.12% | -3,319.73% | -1,149.12% | -91.41% | -39.08% | 156.47% | -4,856.27% | -1,292.91% | -4,049.65% | -12,315.41% | -30,044.64% | -507,223.03% | -9,085.66% | -2,861.61% |
Operating Income | -2.08M | -2.13M | -2.36M | -2.28M | -3.16M | -4.16M | -4.27M | -5.25M | -4.04M | -7.04M | -6.77M | -2.97M | 5.69M | -8.92M | -7.05M | -7.81M | -6.59M | -5.69M | -6.82M | -6.09M | -2.13M |
Operating Income Ratio | -1,659.45% | -5,068.28% | -69,441.67% | -851.51% | -99,835.86% | -42,607.46% | -3,517.78% | -4,556.28% | -3,360.95% | -1,149.75% | -91.50% | -39.16% | 153.43% | -5,050.78% | -1,364.01% | -4,187.45% | -12,689.93% | -31,124.65% | -521,633.44% | -9,309.71% | -2,935.69% |
Total Other Income/Expenses | -17.93K | -20.18K | -7.54K | 105.21K | 1.82M | 684.81K | 3.69M | 1.03M | 943.04K | -3.75M | -5.20M | -11.00K | 9.93M | 2.12M | 1.38M | 1.68M | -202.13K | 941.50K | -1.86K | -7.64K | -8.17M |
Income Before Tax | -2.10M | -2.11M | -2.37M | -1.91M | -1.35M | -3.48M | -576.29K | -4.22M | -3.09M | -7.04M | -6.78M | -2.98M | 5.68M | -6.80M | -5.67M | -6.12M | -6.79M | -5.99M | -6.82M | -6.10M | -10.31M |
Income Before Tax Ratio | -1,673.77% | -5,016.32% | -69,663.11% | -710.50% | -42,468.18% | -35,597.47% | -474.70% | -3,659.77% | -2,575.68% | -1,150.97% | -91.68% | -39.30% | 153.07% | -3,849.43% | -1,097.31% | -3,284.06% | -13,079.04% | -32,731.92% | -521,775.90% | -9,321.39% | -14,175.77% |
Income Tax Expense | 0.00 | 3.00 | -414.73K | -444.86K | -376.92K | -296.15K | -201.80K | -128.69K | -172.67K | -3.95M | -5.39M | -1.97M | 9.72M | -485.29K | -166.29K | -390.90K | 331.44K | 1.43M | 189.08K | -6.10M | -10.31M |
Net Income | -2.10M | -2.11M | -1.96M | -1.46M | -968.47K | -3.18M | -374.49K | -4.09M | -3.09M | -7.04M | -6.78M | -2.98M | 5.68M | -6.80M | -5.67M | -6.12M | -6.79M | -5.99M | -6.82M | 0.00 | 0.00 |
Net Income Ratio | -1,673.77% | -5,016.32% | -57,483.11% | -544.62% | -30,570.36% | -32,565.90% | -308.47% | -3,548.14% | -2,575.68% | -1,150.97% | -91.68% | -39.30% | 153.07% | -3,849.43% | -1,097.31% | -3,284.06% | -13,079.04% | -32,731.92% | -521,775.90% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | 0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.06 | -0.07 | -0.48 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | -0.01 | -0.02 | -0.02 | -0.01 | 0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 | -0.06 | -0.07 | -0.48 |
Weighted Avg Shares Out | 1.61B | 1.35B | 886.62M | 605.49M | 605.49M | 605.49M | 605.40M | 571.72M | 474.39M | 426.69M | 378.27M | 378.27M | 361.59M | 312.92M | 281.81M | 252.53M | 203.18M | 141.27M | 115.27M | 88.48M | 21.42M |
Weighted Avg Shares Out (Dil) | 1.66B | 1.35B | 886.62M | 605.49M | 605.49M | 605.49M | 605.40M | 571.72M | 474.39M | 426.69M | 378.27M | 378.27M | 361.59M | 312.92M | 281.81M | 252.53M | 203.18M | 141.27M | 115.27M | 88.48M | 21.42M |
Source: https://incomestatements.info
Category: Stock Reports